Compare Stocks

Enter up to five stock symbols separated by a comma or space (e.x BAC,WFC,JPM,LON:BARC).

	Amgen	Biogen	Celgene	Gilead Sciences	Illumina
Symbol	NASDAQ:AMGN	NASDAQ:BIIB	NASDAQ:CELG	NASDAQ:GILD	NASDAQ:ILMN
Price Information
Current Price	$171.28	$227.06	$95.24	$66.89	$312.45
52 Week Range	Buy	Hold	Hold	Buy	Buy
Analyst Ratings
Consensus Recommendation	Buy	Hold	Hold	Buy	Buy
Consensus Price Target	$207.7778	$283.2308	$95.31	$81.2111	$353.4608
% Upside from Price Target	21.31% upside	24.74% upside	0.07% upside	21.41% upside	13.13% upside
Trade Information
Market Cap	$103.50 billion	$45.16 billion	$67.54 billion	$85.78 billion	$45.42 billion
Beta	1.15	1.01	1.68	1.14	1.15
Average Volume	3,015,906	2,074,024	10,022,682	7,230,555	970,495
Sales & Book Value
Annual Revenue	$23.75 billion	$13.45 billion	$15.28 billion	$22.13 billion	$3.33 billion
Price / Sales	4.40	3.27	4.40	3.85	13.78
Cashflow	$18.2407 per share	$30.9346 per share	$8.7779 per share	$7.3667 per share	$7.4199 per share
Price / Cash	9.39	7.34	10.85	9.08	42.11
Book Value	$17.76 per share	$71.29 per share	$11.58 per share	$17.33 per share	$27.69 per share
Price / Book	9.64	3.19	8.22	3.86	11.28
Profitability
Net Income	$8.39 billion	$4.43 billion	$4.05 billion	$5.46 billion	$826 million
EPS	$14.40	$26.20	$7.61	$6.15	$5.72
Trailing P/E Ratio	11.89	8.67	12.54	10.88	54.62
Forward P/E Ratio	11.61	7.38	8.17	10.40	40.79
P/E Growth	$2.24	$1.04	$0.44	$0.81	$2.13
Net Margins	34.00%	33.79%	30.10%	26.40%	25.06%
Return on Equity (ROE)	71.02%	41.39%	106.69%	37.98%	23.49%
Return on Assets (ROA)	14.07%	21.63%	17.14%	13.10%	12.95%
Dividend
Annual Payout	$5.80	N/A	N/A	$2.52	N/A
Dividend Yield	3.39%	N/A	N/A	3.77%	N/A
Three-Year Dividend Growth	18.70%	N/A	N/A	20.90%	N/A
Payout Ratio	40.28%	N/A	N/A	40.98%	N/A
Years of Consecutive Dividend Growth	8 Years	N/A	N/A	3 Years	N/A
Debt
Debt-to-Equity Ratio	2.71%	0.43%	2.42%	1.09%	0.27%
Current Ratio	2.77%	2.84%	2.78%	3.62%	3.66%
Quick Ratio	2.53%	2.60%	2.66%	3.53%	3.33%
Ownership Information
Institutional Ownership Percentage	78.01%	88.33%	70.78%	78.68%	90.41%
Insider Ownership Percentage	0.25%	0.29%	0.39%	0.20%	0.38%
Miscellaneous
Employees	21,500	7,800	8,852	11,000	7,300
Shares Outstanding	609.94 million	193.89 million	705.26 million	1.27 billion	147.00 million
Next Earnings Date	7/25/2019 (Estimated)	7/23/2019 (Estimated)	7/25/2019 (Estimated)	7/24/2019 (Estimated)	7/29/2019 (Estimated)
Optionable	Optionable	Optionable	Optionable	Optionable	Optionable
	Amgen	Biogen	Celgene	Gilead Sciences	Illumina

Comparison Ideas: